ASP Isotopes Inc
ASPI
查看详细走势图
5.905USD
-0.045-0.76%
交易中 （美东）报价延迟15分钟
551.39M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-0.76%
5天
+3.78%
1月
-1.09%
6月
-19.22%
今年开始到现在
+30.35%
1年
+29.50%
查看详细走势图
TradingKey ASP Isotopes Inc股票评分
单位: USD 更新时间: 2025-12-23操作建议
ASP Isotopes Inc当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名78/158位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价13.00。中期看，股价处于下降通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
ASP Isotopes Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
3
位分析师
买入
评级
13.000
目标均价
+112.42%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
ASP Isotopes Inc亮点
亮点风险
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
业绩增长期
公司处于发展阶段，最新年度总收入4.14M美元
利润高增长
公司净利润处于行业前列，最新年度总收入4.14M美元
估值合理
公司最新PE估值-4.26，处于3年历史合理位
机构加仓
最新机构持股55.02M股，环比增加0.24%
保罗·都铎·琼斯持仓
明星投资者保罗·都铎·琼斯持仓，最新持仓市值460.69K
ASP Isotopes Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
ASP Isotopes Inc简介
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
公司代码ASPI
公司ASP Isotopes Inc
CEOAinscow (Robert)
网址https://aspisotopes.com/
常见问题
ASP Isotopes Inc(ASPI)的当前股价是多少？
ASP Isotopes Inc(ASPI)的当前股价是 5.905。
ASP Isotopes Inc的股票代码是什么？
ASP Isotopes Inc的股票代码是ASPI。
ASP Isotopes Inc股票的52周最高点是多少？
ASP Isotopes Inc股票的52周最高点是14.490。
ASP Isotopes Inc股票的52周最低点是多少？
ASP Isotopes Inc股票的52周最低点是3.650。
ASP Isotopes Inc的市值是多少？
ASP Isotopes Inc的市值是551.39M。
ASP Isotopes Inc的净利润是多少？
ASP Isotopes Inc的净利润为-35.11M。
现在ASP Isotopes Inc(ASPI)的股票是买入、持有还是卖出？
根据分析师评级，ASP Isotopes Inc(ASPI)的总体评级为买入，目标价格为13.000。
ASP Isotopes Inc(ASPI)股票的每股收益（EPS TTM）是多少
ASP Isotopes Inc(ASPI)股票的每股收益（EPS TTM）是-1.398。
相关品种
